At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 60 enrolled
Drug / intervention
Formoterol fumerate +1 moredrug
Likely dose
Formoterol fumerate 12 microgramsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized, Double Blind, Double Dummy, Placebo Controlled Trial to Compare the Effectiveness of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Asthmatic Children (5-<12 Years) With Acute Bronchial Obstruction Attending Emergency Services
In Brief
A Phase 4 clinical trial evaluating Formoterol fumerate and fenoterol/ipratropium bromide for Acute Bronchial Obstruction, Asthma. Completed, enrolled 60 participants across 2 sites.
Detailed Summary
To determine efficacy and tolerability of inhaled Formoterol vs nebulized Ipatropioum Bromide plus Fenoterol in cumulative sequential doses in asthmatic children (5-\<12 years) with acute bronchial obstruction attending emergency services
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Bronchial Obstruction, Asthma
CountriesVenezuela
Collaborators--
Timeline
Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2007
First PostedApr 2007
Primary CompletionSep 2008
TodayJul 2026
First PostedApr 16, 2007
Enrollment StartMar 1, 2007
Primary CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 19.2 years ago
Interventions
Formoterol fumeratedrug
12 micrograms stat (twice if necessary). Inhaled via aerolizer
fenoterol/ipratropium bromidedrug
0.5 micrograms/0.25 milligrams (20 drops) inhaled via nebulization diluted in 3cc of 0.9% saline.